To confirm that the Fib hydrogel functions solely as a drug reservoir, HFD-fed mice treated with drug-free Fib hydrogel (Fib Gel) showed hepatic pathology identical to the untreated group (Fig. S8), indicating no independent effect on MASLD treatment. This evidence concerns the gene FBL and metabolic dysfunction-associated steatotic liver disease.